People's Hospital of Beijing Daxing District
11
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Clinical Validation of an Artificial Intelligence-Based Scoring System for the Modified Rankin Scale (mRS) in Patients With Stroke
Role: collaborator
Clinical Validation of an Artificial Intelligence-Based G-FAST Score in Patients With Stroke
Role: collaborator
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L)
Role: collaborator
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)
Role: collaborator
Detect and Infer the Severity of COPD by Intelligent Terminal Device
Role: collaborator
Gastrointestinal Endoscopy Artificial Intelligence Cloud Platform in Gastrointestinal Endoscopy Screening
Role: collaborator
Salvational Intervention for Reducing AECOPD Under Severe Air Pollution
Role: collaborator
LIFT-plug vs LIFT, a RCT Trial
Role: collaborator
Research of Systemic Management for Late Preterm Infants Nutrition in China
Role: collaborator
Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
Role: collaborator
Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing
Role: collaborator
All 11 trials loaded